High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This randomized phase III trial is studying high dose interferon alfa to see how well it
works compared to observation only in treating patients with stage II or stage III melanoma
that has been completely removed by surgery.
Phase:
Phase 3
Details
Lead Sponsor:
Hackensack Meridian Health Hackensack University Medical Center